Aug 13, 2020
Hoth Therapeutic Announces That It Has Submitted its Request to Australia Ethics Board to Begin Clinical Trial of BioLexa for Atopic Dermatitis
Jun 12, 2020
Lilly and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life
Jan 29, 2020
Angie Seelal, R-PAC with Advanced Dermatology PC, Shares Tips on Managing Atopic Dermatitis
Dec 07, 2019
Janssen to Acquire Investigational Bermekimab from XBiotech
Nov 26, 2019
Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy
Nov 07, 2019
Survey Shows People Who First Developed Atopic Dermatitis Symptoms As Kids Experience More Severe Symptoms
Oct 24, 2019
Merck Manuals Unveils Answers to Parents' Most Common Eczema Questions
Oct 14, 2019
Hoth Therapeutics Makes Donation to National Eczema Association in Sponsorship of "National Eczema Awareness Month"
Oct 10, 2019
2019 European Dermatological Congress: La Roche-Posay Presents Its Latest Research On Allergies, Atopic Dermatitis & Acne
Oct 08, 2019
Hoth Therapeutics Successfully Completes Phase I of In-Life Dose Escalation Study for Treating Eczema
Oct 03, 2019
Turn Therapeutics(TM) Closes Series B Round to Fuel Lead Atopic Dermatitis Program Trial and Pipeline Expansion
Oct 01, 2019
The National Eczema Association (NEA) Mobilizes Stakeholders To Expose The "Real" Eczema, A Life-Altering Skin Disease Affecting Over 31 Million Americans
Sep 18, 2019
Educational Campaign Helps Teens and Their Caregivers Tackle Everyday Challenges of Living with Moderate-to-severe Atopic Dermatitis
Aug 19, 2019
Eczema Impacts Physical and Mental Health of 31M Americans
Jul 29, 2019
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of its Interleukin-31 Monoclonal Antibody for the Treatment of Atopic Dermatitis in Dogs
Jul 24, 2019
Allergic Diseases: Pipeline Offers Novel Approaches to Treat Increasingly Prevalent Conditions, with Strong Presence of Cytokine Mediators Among First-in-Class Products
Jun 11, 2019
Newly Published Research Shows CLn® BodyWash Significantly Improves Moderate-to-Severe Atopic Dermatitis in Infants, Children and Adolescents
Jun 11, 2019
Biotech Brief: Atopic Dermatitis (Eczema) Revenues Projected to Exceed $6 Billion by 2022
Jun 03, 2019
Itching for Success - Finding New Ways to Tackle House Dust Mite Allergy
Mar 11, 2019
Hoth Therapeutics Announces Dr. Jonathan Zippin as Senior Scientific Advisor